Skip to main content
. 2017 Aug 15;117(8):1202–1210. doi: 10.1038/bjc.2017.266

Table 3. The associations between plasma miRNA levels over time with patient characteristics.

  miR125b
miR141
miR16
miR17-3p
miR200b
miR29a
miR31
miR92a
  Estimate§ (95% CI) P-val Estimate (95% CI) P-val Estimate (95% CI) P-val Estimate (95% CI) P-val Estimate (95% CI) P-val Estimate (95% CI) P-val Estimate (95% CI) P-val Estimate (95% CI) P-val
Intercept 10.54 (9.68, 11.4)   9.5 (7.03, 11.96)   15.38 (14.62, 16.13)   8.96 (7.95, 9.96)   9.65 (8.26, 11.03)   13.59 (12.75, 14.43)   8.56 (7.57, 9.56)   15.81 (14.95, 16.66)  
Age   0.03   0.19   0.13   0.09   0.08   0.26   0.40   0.28
⩾56 −0.45 (−0.87, −0.04)   0.93 (−0.66, 2.52)   −0.29 (−0.66, 0.09)   −0.44 (−0.93, 0.06)   −0.62 (−1.32, 0.07)   −0.24 (−0.65, 0.18)   −0.21 (−0.74, 0.32)   −0.23 (−0.65, 0.19)  
<56a                                
Gender   0.37   0.93   0.55   0.46   0.17   0.42   0.97   0.91
Male −0.19 (−0.62, 0.23)   0.06 (−1.65, 1.77)   0.12 (−0.26, 0.49)   −0.19 (−0.7, 0.31)   −0.5 (−1.21, 0.21)   −0.17 (−0.59, 0.25)   −0.01 (−0.49, 0.47)   0.02 (−0.4, 0.45)  
Femalea                                
Race   0.78   0.61   0.91   0.73   0.74   0.23   0.31   0.87
White 0.09 (−0.55, 0.73)   −0.45 (−2.58, 1.68)   −0.03 (−0.59, 0.52)   0.13 (−0.62, 0.88)   −0.17 (−1.21, 0.87)   0.38 (−0.24, 1.01)   0.41 (−0.43, 1.26)   0.05 (−0.57, 0.68)  
Non-whitea                                
Stage   0.37   0.70   0.83   0.27   0.47   0.09   0.20   0.69
III/IV 0.2 (−0.23, 0.62)   0.32 (−1.68, 2.31)   0.04 (−0.35, 0.43)   0.29 (−0.22, 0.81)   0.28 (−0.49, 1.04)   0.37 (−0.06, 0.81)   0.36 (−0.21, 0.93)   −0.09 (−0.53, 0.35)  
I/IIa                                
Tumour locat   0.77   0.84   0.99   0.58   0.28   0.87   0.59   0.45
Colon −0.06 (−0.48, 0.36)   0.14 (−1.54, 1.81)   0 (−0.38, 0.37)   −0.14 (−0.65, 0.36)   0.4 (−0.32, 1.12)   0.04 (−0.39, 0.46)   0.15 (−0.43, 0.72)   −0.16 (−0.59, 0.26)  
Rectuma                                
Timepoint   0.10   0.61   0.16   0.27   0.74   0.00   0.39   0.49
Baselinea
6 Mo −0.14 (−0.39, 0.1)   −0.07 (−1.09, 0.96)   0.01 (−0.29, 0.31)   −0.13 (−0.41, 0.14)   0.08 (−0.33, 0.49)   0.03 (−0.22, 0.27)   0.28 (−0.16, 0.73)   −0.02 (−0.36, 0.32)  
12 Mo −0.28 (−0.54, −0.02)   −0.49 (−1.5, 0.51)   0.15 (−0.17, 0.47)   0.04 (−0.25, 0.33)   0.24 (−0.19, 0.66)   0.12 (−0.13, 0.37)   0.28 (−0.14, 0.7)   0.23 (−0.13, 0.59)  
24 Mo 0.12 (−0.28, 0.51)   −0.31 (−1.8, 1.18)   0.51 (0.05, 0.97)   0.33 (−0.12, 0.79)   0.08 (−0.49, 0.65)   0.37 (−0.01, 0.74)   −0.02 (−0.65, 0.61)   0.23 (−0.29, 0.75)  

Abbreviations: CI=confidence interval; P-val=P-value; locat=location; Mo=month. † miR203 analysis not done due to small sample size; miRNA measured in ln (normalised copies).

a

Reference.